Background of the Study Cerebral cavernous malformation is a type of vascular malformations characterized by the absence of intervening brain parenchyma. Cerebral cavernous malformations are of two forms, sporadic and familial. About 0.4-0.8% of the population are affected as assessed based on MRI findings and postmortem findings. Three genetic mutations have been identified: CCM1, CCM2, CCM3, with an incidence of 40%, 40% and 20% respectively. Clinical Presentation This author presents 5 members diagnosed with FCCM within a Filipino family. A 25-year-old male who was admitted due to progressive generalized headache of 2 years duration wherein multiple brain lesions on MRI were seen. All members of the family became symptomatic before 30 years of age. 4 out of the 5 members underwent surgery. However, molecular genetic testing was not done. Conclusion In patients diagnosed with cerebral cavernous malformations, a thorough clinical and family history is warranted accompanied by MRI-GRE/T2* to help establish final diagnosis. Confirmation with molecular genetic testing should be offered to all members of the family for proper neurological and genetic care.
No takes yet. Share an insight, caveat, or question.
- et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: